Drug reaction with eosinophilia and systemic symptoms syndrome following vaccination with the AstraZeneca COVID-19 vaccine
Thomas O'Connor, Mika O'Callaghan-Maher, MB, BCh, BAO, Paul Ryan, MB, BCh, BAO, MD, FRCPC and 1 more
JAAD Case Reports · 2022
doi:10.1016/j.jdcr.2021.11.028 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a serious, potentially life-threatening hypersensitivity syndrome that usually occurs after exposure to a drug. The clinical features include rash, edema, fever, lymphadenopathy, and involvement of other organs. The etiopathogenesis is still being investigated. DRESS syndrome tends to occur after ingestion of a drug by a genetically predisposed individual. Reactivation of viruses, including human herpesvirus 6, human herpesvirus 7, Epstein-Barr virus, and human cytomegalovirus, has been reported in patients with DRESS syndrome, but the exact contribution of reactivation of viruses to symptoms and severity has not yet been established.
Abstract licence: CC BY
References9
9 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.